Cons: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with inoperable large volume stage III non-small cell lung cancer

被引：1
|
作者：
Rodrigues, George [1 ]
机构：
[1] London Hlth Sci Ctr, Dept Radiat Oncol, A3-808,790 Commissioners Rd E, London, ON, Canada
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2016年 / 5卷 / 02期
关键词：
PHASE-III; RTOG; 0617; RADIOTHERAPY; TRIAL; CHEMORADIATION; THERAPY;
D O I：
10.21037/tlcr.2016.04.03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：195 / 197
页数：3
相关论文
共 50 条
  • [21] Mutation Profile Prognostic Value in Stage III Non Small Cell Lung Cancer (NSCLC) Patients Treated with Chemo-Radiotherapy (CRT)
    Boros, Angela
    Lacroix, Ludovic
    Lancas, Benjamin
    Adam, Julien
    Pignon, Jean-Pierre
    Caramella, Caroline
    Planchard, David
    Levy, Antonin
    De Montpreville, Vincent
    Deutsch, Eric
    Besse, Benjamin
    Le Pechoux, Cecile
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S288 - S288
  • [22] Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy
    Wen, Shu Wen
    Everitt, Sarah J.
    Bedo, Justin
    Chabrot, Marine
    Ball, David L.
    Solomon, Benjamin
    MacManus, Michael
    Hicks, Rodney J.
    Moeller, Andreas
    Leimgruber, Antoine
    PLOS ONE, 2015, 10 (11):
  • [23] Hypofractionated Accelerated Concurrent Chemoradiotherapy in Inoperable Stage III Non-small Cell Lung Cancer: SOCCAR. A Large Single-Centre Experience
    Patibandla, A.
    Featherstone, C.
    Maclaren, V.
    Lumsden, G.
    Harrow, S.
    Jones, R.
    Chalmers, A. J.
    McLoone, P.
    Hicks, J.
    CLINICAL ONCOLOGY, 2020, 32 (10) : E211 - E211
  • [24] Support and information needs for patients with non-small cell lung cancer receiving concurrent chemo-radiotherapy treatment with curative intent: Findings from a qualitative study
    Punnett, Grant
    Fenemore, Jackie
    Blackhall, Fiona
    Yorke, Janelle
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2023, 64
  • [25] Hypofractionated radiotherapy for medically inoperable stage I non-small cell lung cancer
    Jiang, Wei
    Wang, Jian-Yang
    Wang, Jing-Bo
    Liang, Jun
    Hui, Zhou-Guang
    Wang, Xiao-Zhen
    Zhou, Zong-Mei
    Wang, Lu-Hua
    THORACIC CANCER, 2016, 7 (03) : 296 - 303
  • [26] Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer
    Gerald SMA Kerner
    Leon FA van Dullemen
    Erwin M Wiegman
    Joachim Widder
    Edwin Blokzijl
    Ellen M Driever
    John WG van Putten
    Jeroen JW Liesker
    Tineke EJ Renkema
    Remge M Pieterman
    Marc JF Mertens
    Thijo JN Hiltermann
    Harry JM Groen
    Radiation Oncology, 9
  • [27] Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy
    Dang, Jun
    Li, Guang
    Zang, Shuang
    Zhang, Shuo
    Yao, Lei
    RADIATION ONCOLOGY, 2014, 9
  • [28] Thermal ablation versus radiotherapy for inoperable stage III non-small cell lung cancer: a propensity score matching analysis
    Yang, Wei-Yu
    He, Yu
    Peng, Muyun
    Zhang, Zhe
    Xie, Shouzhi
    Wu, Zeyu
    Hu, Qikang
    Yu, Fenglei
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2023, 40 (01)
  • [29] Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: A systematic review of completed and ongoing studies
    Choy, Hak
    Gerber, David E.
    Bradley, Jeffrey D.
    Iyengar, Puneeth
    Monberg, Matthew
    Treat, Joseph
    Govindan, Ramaswamy
    Koustensis, Andrew
    Barker, Scott
    Obasaju, Coleman
    LUNG CANCER, 2015, 87 (03) : 232 - 240
  • [30] nab-Paclitaxel in Combination With Weekly Carboplatin With Concurrent Radiotherapy in Stage III Non-Small Cell Lung Cancer
    Lammers, Philip Edward
    Lu, Bo
    Horn, Leora
    Shyr, Yu
    Keedy, Vicki
    ONCOLOGIST, 2015, 20 (05): : 491 - 492
12345